Disease-Associated Risk Variants in <i>ANRIL</i> Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.

"Authors' Disclosures P.A. Kanetsky reports grants from University of Pennsylvania during the conduct of the study. A.E. Cust reports grants from National Health and Medical Research Council of Australia during the conduct of the study. S.B. Gruber reports other support from Brogent International LLC outside the submitted work. L. Sacchetto reports work as a biomarker statistician at Bayer AG (Berlin, Germany) on projects not related to the submitted article. N.E. Thomas reports grants from NCI during the conduct of the study. No disclosures were reported by the other authors."

"This work was supported by the NCI (R01CA233524, to N.E. Thomas, M. Berwick, C.B. Begg, and H. Anton-Culver; P01CA206980, to N.E. Thomas and M. Berwick; R01CA112243, to N.E. Thomas; U01CA83180 and R01CA112524, to M. Berwick; R01CA098438, to C.B. Begg; R03CA125829 and R03CA173806, to I. Orlow; P30CA016086 to the University of North Carolina; and P30CA008748 to Memorial Sloan Kettering). A.E. Cust was supported by a NHMRC Career Development Fellowship."